mass
spectrometri
ms
found
numer
applic
life
scienc
high
accuraci
sensit
wide
dynam
rang
addit
mediumto
highthroughput
capabl
featur
make
ms
superior
platform
analysi
variou
biomolecul
includ
protein
lipid
nucleic
acid
carbohydr
recent
ms
appli
protein
detect
character
last
decad
howev
ms
success
use
molecular
diagnost
microbi
viral
infect
notabl
applic
identif
pathogen
genom
sequenc
mutat
detect
dna
methyl
analysi
track
transmiss
character
genet
heterogen
new
develop
vastli
expand
ms
applic
experiment
research
public
health
clinic
field
match
molecular
techniqu
specif
requir
major
ms
platform
produc
power
technolog
molecular
diagnost
benefit
coupl
comput
tool
extract
clinic
inform
msderiv
data
bacteria
dna
analysi
screen
diagnost
research
multiplex
genotyp
sequenc
genom
research
hospit
infect
control
qualiti
control
test
alreadi
review
ms
detect
analyt
biomark
previous
readili
appreci
especi
na
identif
particular
use
merit
mention
thorough
review
state
molecular
diagnost
infecti
diseas
publish
long
ago
includ
basic
technolog
procedur
use
clinic
laboratori
perform
molecular
diagnost
proteom
studi
howev
ms
quickli
gain
recognit
gold
standard
tool
identif
analysi
individu
protein
current
howev
ms
appli
far
beyond
use
protein
character
includ
type
analyt
includ
na
ms
detect
diagnost
marker
rapid
take
millisecond
second
prepar
analyt
highli
amen
autom
addit
broaden
field
possibl
applic
ms
easili
adapt
differ
scale
detect
applic
low
mediumand
highthroughput
clinic
screen
diagnost
test
subpicomolar
amount
analyt
detect
without
fluoresc
radioact
isotop
label
use
antibodi
hybrid
probe
use
detect
materi
interest
directli
attach
intermedi
detector
molecul
thu
confer
high
sensit
detect
direct
detect
significantli
simplifi
ms
diagnost
applic
detect
system
na
ms
easili
coupl
wide
avail
dna
amplif
techniqu
qualiti
combin
capabl
multiplex
test
differ
analyt
time
make
ms
particularli
suitabl
rapid
molecular
diagnost
clinic
set
ms
uniqu
suit
support
multipl
divers
applic
throughput
multiplex
capac
ms
help
reduc
cost
test
ms
applic
base
direct
measur
two
intrins
properti
bioanalyt
molecular
mass
charg
mass
spectromet
consist
three
function
unit
first
unit
ion
sourc
use
ioniz
analyt
transfer
ga
phase
second
unit
mass
analyz
serv
separ
ion
masstocharg
ratio
mz
turn
defin
tof
variou
configur
use
vacuum
chamber
static
dynam
magneticelectr
field
separ
ion
third
unit
detector
devic
electron
multipli
fast
oscilloscop
detect
ion
great
varieti
ioniz
method
use
atmospher
pressur
spray
chemic
electron
heat
ion
atom
bombard
ioniz
techniqu
requir
chemic
electr
ioniz
energi
rich
frequent
result
unpredict
decomposit
na
analyt
softer
ioniz
approach
use
electrospray
devic
matrix
carrier
laser
ion
sourc
esi
maldi
solv
degrad
problem
account
major
current
use
ioniz
techniqu
addit
issu
aris
work
na
depurin
gener
salt
adduct
resolv
util
improv
reagent
cleanup
method
discoveri
ribonucleotid
stabl
deoxyribonucleotid
esim
soft
techniqu
analyt
dissolv
organ
solvent
like
methanol
acetonitril
sometim
combin
acet
acid
inject
conduct
capillari
high
voltag
appli
result
emiss
aerosol
charg
droplet
sampl
aerosol
travel
section
decreas
pressur
lead
format
gasphas
ion
analyt
esi
typic
coupl
autom
autosampl
wellplat
format
injector
liquid
chromatographi
control
flow
rate
sampl
deliveri
buffer
zone
sampl
rate
sampl
detect
sever
minut
per
sampl
analyzerdetector
fticr
detect
gener
ion
simultan
differenti
rotat
frequenc
transform
specif
mass
read
microtof
fticr
detect
great
accuraci
high
resolut
schemat
represent
esim
shown
figur
revolutionari
develop
soft
ioniz
techniqu
short
time
span
process
util
analysi
pcramplifi
dna
product
studi
noncoval
molecular
complex
peptid
glycan
technolog
improv
dna
fragment
prepar
led
introduct
ibi
bioscienc
novel
platform
rapid
identif
pathogen
process
mediumto
highthroughput
capabl
appli
esim
essenc
combin
accuraci
sensit
multilocu
sequenc
type
speed
throughput
accuraci
ms
two
major
class
matrix
hot
cool
desorb
laser
energi
use
malditof
ms
hot
matric
higher
desorptionion
energi
result
excess
fragment
analyt
thu
suitabl
detect
small
rna
molecul
cool
matric
use
larger
oligonucleotid
caus
littl
fragment
commonli
use
matric
rna
mix
matric
dna
acid
matrix
crystal
solid
inert
surfac
sampl
imbed
matrix
dispens
nanoquant
desorb
ioniz
short
ns
uvlas
irlas
puls
ion
acceler
electr
field
kinet
energi
sent
fieldfre
drift
flight
vacuum
tube
ion
differ
mz
valu
separ
veloc
ion
depend
mz
heavier
molecul
travel
lower
speed
thu
reach
detector
later
detect
analyt
singl
target
spot
accomplish
sever
second
analysi
na
tof
need
ioniz
analyt
reach
detector
record
use
deriv
analyt
mass
method
resolut
reach
da
allow
discrimin
singl
nucleotid
schemat
represent
malditof
ms
shown
figur
esim
malditof
ms
given
appropri
analyz
sensit
small
variat
primari
structur
na
capabl
discrimin
even
singl
nucleotid
differ
capac
malditof
ms
significantli
improv
develop
better
matric
method
elimin
adductform
agent
novel
biochemistri
predomin
current
use
malditof
ms
field
genotypingsnp
type
methyl
analysi
quantit
gene
express
analysi
resequenc
presenc
certain
phenotyp
biochem
genet
characterist
use
routin
clinic
laboratori
identif
differenti
microb
molecular
diagnost
base
specif
recoveri
detect
certain
genom
fragment
na
character
techniqu
plasmid
profil
fragment
length
polymorph
pcrbase
system
significantli
improv
sensit
specif
throughput
detect
microbi
pathogen
directli
clinic
sampl
applic
techniqu
howev
limit
mostli
detect
pathogen
difficult
cultur
vitro
sequenc
analysi
amplifi
microbi
dna
allow
even
accur
character
pathogen
molecular
identif
bacteria
virus
base
signific
sequenc
specif
na
differ
organ
first
applic
ms
molecular
microbiolog
diagnost
detect
pcr
product
gener
genom
region
pathogen
pathogen
specif
detect
use
entir
pcr
fragment
sitespecif
cleavag
product
fragment
mani
sensit
pathogen
identif
assay
requir
amplif
particular
label
signatur
molecul
visual
detect
na
gener
involv
size
separ
detect
label
probe
one
first
success
applic
malditof
esi
approach
character
pcr
amplicon
cystic
fibrosi
transmembran
conduct
regul
gene
similar
assay
principl
appli
shortli
success
identif
immobil
pcr
product
hepat
b
viru
hbv
obtain
serum
demonstr
identif
ms
fast
reliabl
method
pathogen
detect
although
applic
pathogen
detect
particularli
success
mere
use
ms
detect
system
place
exampl
gel
electrophoresi
reson
mani
research
mainli
seem
complex
ms
also
coincid
introduct
realtim
pcr
attract
eas
detect
quantif
pcr
product
took
away
develop
ms
applic
molecular
diagnost
howev
ms
surpass
electrophoresi
rapid
sensit
detect
system
allow
precis
size
molecul
interest
also
provid
inform
nucleotid
composit
charg
temporarili
neglect
potenti
ms
reviv
expand
need
develop
higher
throughput
dna
analysi
techniqu
discoveri
novel
ms
applic
molecular
diagnost
beyond
simpl
detect
yet
anoth
advantag
ms
platform
gener
allow
simultan
detect
multipl
analyt
initi
ms
method
appli
simultan
detect
two
bacteri
pathogen
along
came
multiplex
detect
human
herpesvirus
human
papillomavirus
hpv
variant
hbv
restrict
fragment
length
polymorph
rflp
also
tool
choic
organ
identif
detect
polymorph
coupl
rflp
illustr
figur
ms
produc
especi
effici
technolog
replac
gel
electrophoresi
ms
separ
restrict
fragment
gener
rflp
recent
implement
detect
avian
influenza
virus
genotyp
hepat
c
viru
hcv
detect
drugresist
hbv
variant
applic
ms
analyz
product
robust
sensit
na
technolog
realtim
pcr
rflp
uracil
dna
glycosyl
improv
identif
pathogen
mere
highthroughput
capabl
ms
also
new
layer
accur
molecular
inform
could
acquir
phylogenet
analysi
rdnagen
sequenc
purpos
microbi
identif
consid
gold
standard
year
specif
reproduc
molecular
identif
mycobacterium
spp
success
achiev
basespecif
cleavag
transcript
gener
rdna
amplicon
ms
separ
result
rna
fragment
new
biosensor
technolog
triangul
identif
genet
evalu
biolog
risk
tiger
ibi
platform
develop
use
esim
molecular
element
test
start
rna
base
add
use
broadrang
primer
aim
essenti
housekeep
gene
bacteri
fungal
protozoan
pathogen
specif
genom
region
virus
target
pcr
amplicon
mix
intern
calibr
amplicon
known
concentr
analysi
accomplish
match
base
composit
detect
fragment
databas
composit
signatur
predetermin
everi
particular
organ
differ
isol
pathogen
differ
slightli
system
handl
divers
build
probabl
space
composit
constraint
speci
stepwis
process
joint
maximum
likelihood
maximum
likelihood
cluster
sampl
assign
organ
id
abund
estim
algorithm
involv
one
locu
per
pathogen
redund
afford
high
accuraci
pathogen
identif
achiev
direct
sequenc
plexid
current
version
technolog
expand
viral
detect
schemat
represent
test
process
pipelin
shown
figur
tiger
found
mani
applic
includ
detect
identif
acinetobact
speci
novel
coronaviru
respons
recent
sar
outbreak
alphavirus
platform
appli
success
global
surveil
emerg
influenza
virus
quantit
detect
orthopoxvirus
vectorborn
flavivirus
character
zoonot
influenza
virus
prior
pandem
spread
recent
modif
platform
focu
viral
type
plexid
certifi
vitro
diagnost
europ
although
identif
pathogen
use
ms
usual
accomplish
direct
detect
pathogenspecif
na
altern
approach
base
use
cleavabl
masstag
recent
develop
indirect
detect
pathogen
avoid
mani
limit
direct
detect
na
aforement
fragment
salt
adduct
format
masstag
approach
offer
greater
robust
sensit
detect
well
eas
multiplex
indirect
detect
method
take
advantag
ms
abil
detect
differenti
among
fairli
small
molecular
tag
cleav
na
identifi
specif
target
may
amen
ms
size
constraint
illustr
figur
recent
develop
base
use
photocleav
linker
tag
molecul
pcr
elisa
quantif
coupl
ms
howev
effect
applic
masstag
method
multiplex
detect
pathogen
still
await
valid
noth
els
showcas
capac
ms
accur
identifi
singlepoint
nucleotid
differ
applic
dna
sequenc
malditof
ms
appli
sequenc
short
dna
fragment
year
malditof
ms
product
basespecif
dideoxynucleotid
chaintermin
dnasequenc
reaction
catalyz
modifi
dna
polymeras
allow
read
short
stretch
sequenc
nucleotid
length
littl
fmol
materi
anoth
earli
success
record
long
sequenc
ladder
gener
immobil
synthet
templat
resolv
sequenc
includ
primer
essenc
solidphas
sanger
dna
sequenc
follow
detect
extend
product
malditof
ms
illustr
figur
sequenc
capac
approach
limit
rang
possibl
masssiz
acquisit
window
rang
mass
size
dna
product
effect
resolv
ms
addit
length
sequenc
restrict
presenc
primer
extens
dna
product
thu
coupl
ms
sanger
dna
sequenc
seem
impract
albeit
applic
de
novo
sequenc
howev
particularli
suitabl
compar
dna
sequenc
aim
detect
one
mutat
short
genom
fragment
resolut
hardtosequ
fragment
could
separ
reliabl
standard
electrophoret
manner
due
compress
fals
termin
ms
quit
suitabl
fast
highfidel
altern
convent
sequenc
procedur
highthroughput
autom
screen
mutat
need
aforement
applic
exemplifi
feasibl
dna
sequenc
use
ms
howev
take
advantag
ms
capac
accur
resolut
complex
molecular
mixtur
therefor
could
compet
success
gelbas
technolog
ms
howev
sensit
nucleotid
composit
na
electrophoresi
use
convent
sequenc
thu
allow
greater
resolut
short
dna
rna
fragment
provid
opportun
develop
novel
ms
applic
sequenc
use
basespecif
cleavag
target
dna
applic
mani
oligonucleotides
fragment
gener
cleavag
may
length
differ
nucleotid
composit
separ
fragment
present
signific
challeng
gel
electrophoresisbas
technolog
fine
resolut
afford
ms
allow
accur
identif
fragment
critic
improv
molecular
techniqu
allow
resequenc
fragment
signific
size
came
less
decad
ago
introduct
transcriptioncoupl
basespecif
rnase
cleavag
technolog
use
pcr
amplicon
gener
genespecif
primer
one
flank
region
amplicon
subject
transcript
either
polymeras
presenc
four
nucleotid
obtain
transcript
dna
strand
utp
ctp
modifi
prevent
cleavag
rnase
reaction
carri
isotherm
transcript
cleavag
occur
simultan
product
resolv
malditof
ms
result
mass
pattern
match
automat
silico
gener
cleavag
pattern
appropri
referencesequ
set
schemat
represent
process
process
pipelin
shown
figur
respect
although
approach
somewhat
ineffici
de
novo
sequenc
requir
substanti
refer
databas
henc
great
comput
power
numer
applic
resequenc
genotyp
mutat
discoveri
recent
comprehens
review
avail
dna
sequenc
strategi
cover
six
differ
approach
sequenc
name
dideoxynucleotid
termin
cyclic
array
sequencingbyhybrid
microelectrophoresi
ms
nanopor
sequenc
acknowledg
role
ms
fine
tool
address
specif
problem
resolv
method
especi
area
direct
rna
sequenc
resequenc
methyl
analysi
rightli
argu
ms
may
outcompet
nextgener
sequenc
ng
approach
cyclic
array
roch
illumina
helico
appli
biosystem
nanopor
sequenc
agil
oxford
nanopor
technolog
noblegen
de
novo
highthroughput
applic
methyl
central
epigenet
process
key
understand
pathogenesi
carcinogenesi
particular
import
gene
regul
strongli
implic
develop
cancer
respons
infecti
agent
accept
relationship
dna
methyl
chromatin
structur
human
malign
propos
host
use
chromatin
methyl
defens
dna
virus
cpg
site
host
genom
methyl
regul
gene
express
facilit
recognit
pathogenassoci
dna
methyl
identifi
host
defens
mechan
event
infect
hbv
demonstr
methyl
viral
dna
lead
downregul
hbv
gene
express
first
assay
analysi
precis
quantif
methyl
cpg
posit
simplex
multiplex
reaction
base
malditof
ms
methyl
assay
base
principl
aforement
resequenc
assay
howev
requir
sodium
bisulf
treatment
dna
interest
prior
enzymat
procedur
treatment
preferenti
deamin
cytosin
residu
uracil
lead
chang
sequenc
comparison
treat
untreat
sampl
cleav
rnase
reveal
number
locat
methyl
site
genotyp
infecti
agent
need
studi
agent
epidemiolog
detect
transmiss
make
clinic
decis
appropri
cours
treatment
certain
viral
genotyp
associ
develop
aggress
acut
chronic
diseas
develop
cancer
differ
strategi
strain
discrimin
like
hybrid
ligat
cleavag
primer
extens
popular
combin
ms
detect
genotyp
larg
bodi
data
present
show
reliabl
discrimin
sequenc
differ
singl
nucleotid
posit
permit
rapid
character
cultur
uncultur
bacteria
genotyp
identif
achiev
ms
separ
dna
fragment
gener
pcr
product
basespecif
dna
degrad
uracil
dna
glycosyl
combin
alkalin
treatment
strategi
base
basespecif
degrad
dna
rna
molecul
proven
sensit
minor
variat
nucleotid
sequenc
among
genet
relat
organ
specif
reproduc
type
mycobacterium
spp
achiev
success
coupl
molecular
approach
ms
analysi
exampl
highli
multiplex
spoligotyp
multilocu
sequenc
type
exampl
malditof
ms
viral
type
includ
effici
primer
extens
assay
base
region
develop
identif
major
genotyp
subtyp
hcv
altern
hcv
genotyp
assay
base
restrict
fragment
mass
polymorph
rfmp
analysi
region
assay
practic
advantag
capabl
identifi
mix
viral
genotyp
present
concentr
low
accur
determin
rel
abund
without
need
genet
clone
improv
rfmpbase
malditof
ms
assay
mediat
use
artifici
introduc
type
ii
restrict
enzym
site
develop
highresolut
genotyp
hpv
assay
shown
success
identifi
least
differ
hpv
genotyp
develop
specif
assess
genet
polymorph
use
analysi
snp
insert
delet
repeat
use
detect
mass
differ
specif
probe
singl
nucleotid
extens
product
probe
uniqu
mass
extend
oligonucleotid
identifi
malditof
ms
figur
process
pipelin
shown
figur
massarray
assay
abl
reliabl
distinguish
differ
mass
short
oligonucleotid
detect
window
da
assay
detect
minor
allel
present
dna
mixtur
readili
amen
multiplex
suitabl
highthroughput
genotyp
sequencebas
highthroughput
method
massarray
platform
develop
detect
oncogen
hpv
genotyp
multiplex
pcr
product
approach
shown
outperform
revers
dotblot
hybrid
sensit
cost
turnaround
time
success
assay
type
influenza
virus
develop
use
esim
platform
virus
present
particular
challeng
type
assay
replic
machineri
gener
high
error
rate
result
extens
genet
variabl
intraand
interhost
viral
popul
one
first
hbv
genotyp
assay
adapt
ms
base
malditof
recent
improv
approach
hbv
genotyp
design
implement
use
massarray
platform
assay
detect
genotyp
accur
capabl
identifi
new
hbv
variant
genotyp
achiev
comparison
mass
pattern
experiment
obtain
gene
test
strain
computersimul
hbv
variant
known
genotyp
multipl
paramet
viral
titer
genotyp
heterogen
qualiti
pcr
product
ms
pattern
care
evalu
design
test
assay
qualiti
pcr
product
found
properti
significantli
affect
accuraci
hbv
genotyp
assay
outcom
complet
concord
goldstandard
sequenc
result
although
capabl
specifi
minor
hbv
genotyp
mixedgenotyp
infect
case
predomin
genotyp
never
report
erron
given
suffici
qualiti
pcr
product
ms
pattern
low
match
score
refer
dataset
indic
either
mixedgenotyp
infect
presenc
new
hbv
variant
flexibl
assay
design
allow
rapid
adjust
detect
new
hbv
variant
simpli
updat
refer
dataset
variant
highli
amen
autom
highthroughput
detect
assay
commend
molecular
surveil
hbv
infect
lowcost
altern
sequencebas
method
middl
last
decad
alreadi
clear
recognit
na
analysi
ms
particular
malditof
ms
would
emerg
postgenom
sequenc
era
versatil
tool
viral
type
analysi
polymorph
sequenc
dna
methyl
rna
express
multiplex
manner
identifi
genet
divers
mean
detect
snp
instead
use
complet
genom
sequenc
scale
practic
approach
identifi
import
genet
variant
pathogen
figur
ms
especi
applic
snp
analysi
introduct
basespecif
cleavag
concept
msbase
snp
analysi
found
mani
field
applic
multilocu
genotyp
massiv
parallel
test
becom
prefer
strategi
accur
highthroughput
human
snp
detect
malditof
ms
among
power
wide
use
technolog
platform
major
advantag
ms
applic
molecular
diagnost
origin
unmatch
capac
ms
decod
reliabl
composit
complex
mixtur
short
dna
rna
fragment
amen
highthroughput
analysi
mixtur
basespecif
degrad
pcr
product
extens
use
specif
detect
pathogen
pathogen
genotyp
even
minor
genet
variat
associ
exampl
drug
resist
resolut
product
basespecif
degrad
ms
dramat
improv
speed
throughput
accuraci
detect
mani
virus
gener
genet
variant
spontan
select
pressur
exampl
antivir
therapi
variat
confer
drug
resist
affect
viru
replic
capac
result
therapeut
failur
autom
malditof
ms
use
detect
differ
known
mutat
revers
transcriptas
gene
precor
promot
basal
core
promot
hbv
genom
ms
direct
sequenc
show
discord
variant
call
howev
ms
abl
detect
twice
mani
minor
variant
direct
sequenc
achiev
close
full
autom
sensit
detect
rfmpbase
malditof
ms
approach
develop
detect
mutat
hbv
polymeras
particularli
ymdd
motif
assay
found
suffici
sensit
earli
detect
hbvbreakthrough
infect
patient
therapeut
treatment
polymeras
inhibitor
similar
approach
show
remark
abil
detect
copi
hbv
genom
correctli
identifi
sever
known
viral
variant
find
minor
intrahost
viral
variant
undetect
test
method
estim
rel
abund
variant
rfmpbase
malditof
assay
evalu
comparison
commerci
avail
innolipa
hbv
dr
assay
base
revers
hybrid
lineprob
technolog
ms
assay
provid
greater
detect
sensit
mutat
interest
identifi
addit
minor
intrahost
viral
subpopul
herald
clinic
applic
mechan
viral
persist
continu
subject
investig
import
aspect
chronic
hcv
infect
quasispeci
natur
viral
popul
particularli
well
document
hypervari
region
glycoprotein
recent
studi
show
character
quasispeci
divers
amino
acid
level
could
help
predict
outcom
hcv
infect
accur
character
hcv
quasispeci
requir
clone
pcr
product
follow
sequenc
mani
clone
method
base
vitro
translat
pcr
amplicon
follow
ms
analysi
result
peptid
mix
develop
character
hcv
divers
infect
host
assay
shown
detect
weekli
chang
hcvinfect
chimpanze
coincid
emerg
neutral
antibodi
use
msbase
method
convent
method
clone
sequenc
weekli
chang
quasispeci
hcvinfect
chimpanze
could
follow
detect
great
sensit
analysi
genet
heterogen
viral
popul
found
especi
import
evalu
safeti
liveattenu
vaccin
sinc
presenc
even
small
quantiti
mutant
revert
may
associ
incomplet
unstabl
attenu
viral
strain
howev
assess
presenc
mutant
viral
popul
labori
ms
provid
rapid
accur
platform
assess
recent
dna
massarray
use
evalu
genet
variat
liveattenu
mump
viru
vaccin
strong
correl
estim
variat
made
use
restrict
enzym
cleavag
analysi
pcr
fragment
indic
util
malditof
ms
routin
qualiti
control
live
viral
vaccin
assess
genet
stabil
quantit
monitor
genet
variat
transmiss
fundament
viral
properti
essenti
dissemin
infect
diseas
key
surveil
infecti
diseas
molecular
detect
transmiss
complex
task
involv
identif
viru
assess
genet
associ
among
variant
major
assumpt
genomebas
detect
transmiss
genet
composit
viral
strain
pass
one
patient
anoth
remain
approxim
ident
detect
transmiss
especi
pertain
virus
often
present
challeng
particular
agent
concern
caus
chronic
diseas
agent
opportun
accumul
multipl
mutat
genet
heterogen
hallmark
mani
virus
hcv
exampl
exist
multipl
variant
quasispeci
infect
individu
consensu
sequenc
hcv
gene
also
commonli
appli
determin
genet
related
among
hcv
strain
identifi
hcv
transmiss
howev
consensu
sequenc
adequ
repres
entir
hcv
popul
present
host
particularli
chronic
infect
patient
viral
genet
heterogen
extens
accur
identif
hcv
strain
involv
transmiss
achiev
match
genet
composit
viral
popul
sampl
infect
host
sinc
one
variabl
region
hcv
genom
analysi
intrahost
variant
frequent
use
identif
track
hcv
transmiss
analysi
involv
separ
individu
variant
either
genet
clone
pcr
amplicon
pcr
clone
use
end
point
limitingdilut
cdna
sequenc
variant
ng
technolog
coupl
separ
genet
variant
sequenc
thu
significantli
simplifi
assess
viral
heterogen
howev
high
rate
sequenc
error
gener
per
dna
read
problemat
represent
intrahost
viral
heterogen
potenti
hindranc
adopt
ng
approach
detect
transmiss
recent
malditof
ms
explor
identif
hcv
transmiss
ms
profil
msp
gener
basespecif
cleavag
rna
transcript
deriv
pcr
fragment
use
sourc
inform
nucleotid
sequenc
structur
intrahost
viral
popul
assay
detect
pattern
short
rna
fragment
kmer
found
kmer
structur
ms
data
close
reflect
heterogen
viral
popul
sinc
genet
distanc
estim
use
msp
affect
sequenc
heterogen
composit
intrahost
hcv
popul
msp
shown
highli
applic
evalu
phylogenet
relationship
among
hcv
strain
analys
reveal
fundament
similar
mspand
sequencebas
distanc
make
suitabl
genet
detect
transmiss
separ
msp
distanc
among
genet
relat
unrel
case
clear
permit
discrimin
hcv
variant
involv
outbreak
detect
transmiss
requir
complet
assess
phylogenet
relationship
among
hcv
variant
therefor
achiev
use
threshold
visual
use
simpl
linkag
graph
mspbase
detect
hcv
transmiss
match
accuraci
sequencebas
method
pave
way
applic
ms
molecular
surveil
viral
hepat
emerg
novel
technolog
summit
emphas
import
potenti
role
ms
clinic
recogn
technolog
discoveri
enabl
find
multipl
biomark
yet
translat
clinic
practic
encourag
clinician
scientist
adopt
technolog
identifi
pathogen
alon
also
reveal
resist
determin
present
pathogen
last
decad
ms
emerg
rapid
costeffect
highli
reproduc
techniqu
multipl
versatil
applic
molecular
diagnost
mani
studi
demonstr
effici
applic
ms
detect
viral
pathogen
esim
especi
success
applic
although
compet
technolog
like
microchip
microarray
field
ms
stand
major
advantag
ms
compet
technolog
evid
relat
investig
paramet
viral
infect
requir
assess
genet
heterogen
exampl
detect
mutat
predict
outcom
therapeut
treatment
detect
transmiss
genet
related
among
viral
variant
although
technolog
ng
assess
paramet
effici
ms
unpreced
simplic
provid
dens
accur
genet
inform
directli
associ
variabl
paramet
viral
infect
properli
match
molecular
technolog
compat
mass
detect
rang
exampl
basespecif
cleavag
dna
rna
molecul
ms
provid
unparallel
capac
costeffect
highthroughput
detect
genet
marker
crucial
molecular
surveil
viral
infect
diseas
well
patient
manag
malditof
ms
especi
use
gener
informationdens
data
genet
composit
intrahost
viral
popul
appear
degrad
long
na
molecul
short
kmer
produc
ms
pattern
accur
reflect
primari
structur
also
divers
frequenc
intrahost
viral
variant
repres
pcr
fragment
amplifi
viral
genom
viral
genet
heterogen
long
found
associ
outcom
infect
therapi
treatment
current
genet
heterogen
assess
use
ng
genet
clone
limit
dilut
follow
sequenc
although
dna
sequenc
use
ms
effici
ng
analysi
ms
pattern
directli
without
convers
sequenc
seem
provid
adequ
estim
genet
composit
viral
popul
use
measur
genet
related
among
viral
strain
detect
viral
transmiss
howev
msgener
data
structur
significantli
differ
sequenc
therefor
requir
differ
comput
mathemat
approach
extract
inform
relev
physician
patient
manag
public
health
practition
implement
develop
surveil
prevent
activ
applic
ms
molecular
diagnost
becom
dynam
area
research
signific
implic
medicin
public
health
advanc
develop
gener
specif
match
molecular
techniqu
two
major
ms
platform
esi
malditof
ms
detect
system
suit
identif
complex
genet
marker
without
invok
sequenc
envis
futur
develop
msbase
molecular
diagnost
link
novel
method
extract
clinic
epidemiolog
relev
inform
diseas
sever
drug
resist
vaccin
escap
transmiss
genet
marker
use
specif
design
comput
mathemat
model
import
aspect
ms
technolog
potenti
applic
rapid
detect
microb
caus
hospit
infect
coupl
appropri
rapid
sensit
technolog
diagnosi
prevent
infect
ms
also
impact
area
qualiti
control
steril
blood
product
food
safeti
integr
molecular
comput
approach
ms
produc
diagnost
assay
broad
routin
applic
public
health
clinic
practic
last
decad
mass
spectrometri
ms
emerg
rapid
costeffect
highli
reproduc
techniqu
multipl
versatil
applic
molecular
diagnost
maldi
esi
two
major
platform
applic
ms
molecular
diagnost
esim
especi
effici
detect
viral
pathogen
malditof
effici
assess
viral
clinic
factor
associ
genet
heterogen
viral
pathogen
exampl
detect
specif
mutat
predict
outcom
therapeut
treatment
detect
transmiss
identif
genotyp
assess
fine
genet
related
among
viral
variant
ms
unpreced
efficaci
provid
dens
accur
genet
inform
directli
associ
clinic
paramet
viral
infect
thu
success
compet
power
technolog
nextgener
sequenc
structur
msgener
data
significantli
differ
sequenc
present
one
major
challeng
applic
ms
molecular
diagnost
futur
develop
msbase
molecular
diagnost
viral
infect
conting
success
match
ms
molecular
technolog
applic
comput
approach
identif
complex
genet
marker
ms
pattern
directli
integr
molecular
comput
approach
ms
produc
diagnost
assay
broad
routin
applic
public
health
clinic
practic
gener
sequenc
ladder
presenc
one
specif
primer
regular
nucleotid
dideoxynucleotid
polymeras
result
random
termin
fragment
posit
allow
discrimin
two
fragment
one
ad
nucleotid
sequenc
transcript
polymeras
coupl
rnase
singl
basespecif
cleavag
process
queri
strand
amplicon
interest
result
mass
fingerprint
contain
inform
four
nucleotid
use
deriv
fragment
sequenc
genotyp
heterogen
discov
new
mutat
silico
pattern
comparison
comprehens
refer
set
e
snp
identif
multiplex
pcr
product
queri
specif
probe
design
immedi
upstream
snp
interest
extend
presenc
ddntp
mix
result
extend
probe
present
mass
signatur
identifi
snp
sequenc
depend
assay
design
eg
multiplex
product
could
use
directli
ms
result
mass
pattern
use
organ
identif
ms
mass
spectrometri
sap
shrimp
alkalin
phosphatas
